A study at the University of Illinois found that stem cell injections can promote angiogenesis, or blood vessel generation, which improves the circulation problems associated with diabetes. The condition in question is peripheral artery disease or PAD, in which patients suffer from restricted blood flow caused by plaque on the walls of the arteries; most typically in the leg. This is due in part to poor circulation in diabetic patients which can cause moderate to severe pain during any movement of the leg. It can also lead to ulcers, sores and, in severe cases, gangrene, which can lead to amputation. In an animal model, stem cell injections were shown to improve blood flow and circulation in problematic areas. They also altered the gene expression of surrounding cells to reduce inflammation, which typically exacerbates the problem. PAD currently lacks effective treatments options and is difficult to diagnose until it has progressed severely hence, the study points to a potential breakthrough therapy that utilizes the patient’s own stem cells.
Stem cell injections may help patients avoid the pain and discomfort of the disease, as well as avoid drastic and invasive treatment options such as stent insertion surgery and, in severe cases, amputation. Dr. Lawrence Dobrucki, who is leading the study, states that "… we used a more nature-inspired therapy to promote angiogenesis in PAD-affected limbs and used the stem cells [because] they know what to release, how much and when to stop, for example. They also respond to and modify the tissue microenvironment to optimize their therapeutic effect."
As treatments emerge, we believe the best stem cells to use will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn how to bank your own valuable stem cells to insure your future health, visit www.StemSave.com or call 877-783-6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.